Pacific Edge Senior Medical Director Dr. Jay Jhaveri hosts an expert panel discussion with Dr. Evan Goldfischer, Dr. Kristen Scarpato, Dr. Ron Loo, and Dr. Zachary Klaassen focused on the use of Cxbladder Triage, a urine-based tumor marker (UBTM) test, in the evaluation of patients presenting with microhematuria.
In this mini-clip, Dr. Jhaveri and Dr. Goldfischer discuss the use of Cxbladder to support revenue cycle management. Watch the full panel discussion here: • The Utility of Cxbladder Triage in Microhe... .
Learn more:
Email us at [email protected] / [email protected]
Visit us at www.cxbladder.com
Biographies:
Evan Goldfischer, MD, MBA, FACS, Premier Medical Group, Poughkeepsie, NY
Kristen Scarpato, MD, MPH, Associate Professor, Department of Urology, Vanderbilt University, Nashville, TN
Ronald K. Loo, MD, Urologist, Kaiser Permanente, CA
Zachary Klaassen, MD, MSc, Urologic Oncologist, Assistant Professor Surgery/Urology at the Medical College of Georgia at Augusta University, Wellstar MCG, Georgia Cancer Center, Augusta, GA
Jay Jhaveri, MD, Senior Medical Director, Pacific Edge
References:
(*) Barocas DA, Lotan Y, Matulewicz RS, Raman JD, Westerman ME, Kirkby E, Pak L, Souter L. Updates to Microhematuria: AUA/SUFU Guideline (2025). J Urol. 0(0). doi: 10.1097/JU.0000000000004490.
Информация по комментариям в разработке